Broadwood Capital Inc., 10% Owner at Lineage Cell Therapeutics, Inc. (LCTX), bought 24,553 shares at $0.99 ($24K) on 2019-08-13, disclosed to the SEC on 2019-08-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.99 | 10,000 | $10K | 41.2% |
| 2 | $0.98 | 1,407 | $1K | 5.7% |
| 3 | $0.97 | 13,146 | $13K | 53.1% |
| Total | $0.98 avg | 24,553 | $24K | 100% |
| Filing → |
| STAA | BUY | 2025-03-20 | $7.2M | — | Filing → |
| STAA | BUY | 2025-03-06 | $964K | — | Filing → |
| STAA | BUY | 2025-03-03 | $22.5M | — | Filing → |